Scarica l'app Stockscreener
6.50
12.07%
0.70
Dopo l'orario di chiusura:
6.50
Precedente Chiudi:
$5.80
Aprire:
$5.94
Volume 24 ore:
36,345
Relative Volume:
4.38
Capitalizzazione di mercato:
$306.37M
Reddito:
$27,600
Utile/perdita netta:
$-36.04M
Rapporto P/E:
-8.1576
EPS:
-0.7968
Flusso di cassa netto:
$-1.66M
1 W Prestazione:
+22.64%
1M Prestazione:
+47.39%
6M Prestazione:
+88.41%
1 anno Prestazione:
+21.95%
Intervallo 1D:
$5.93
$7.29
Intervallo di 1 settimana:
$5.00
$7.29
Portata 52W:
$2.76
$7.29
Nanobiotix Adr Stock (NBTX) Company Profile
Confronta NBTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NBTX
Nanobiotix Adr
|
6.50 | 241.29M | 27,600 | -36.04M | -1.66M | -0.7968 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Nanobiotix Adr Stock (NBTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-28 | Iniziato | Guggenheim | Buy |
| 2023-12-08 | Iniziato | Leerink Partners | Outperform |
| 2021-01-06 | Iniziato | Evercore ISI | Outperform |
Nanobiotix Adr Borsa (NBTX) Ultime notizie
Nanobiotix (NASDAQ:NBTX) Stock Price Down 2.5% – Should You Sell? - Defense World
Nanobiotix announces regulatory harmonization, new patent for JNJ-1900 - TipRanks
Nanobiotix Sa ADR Reports Q1 2025 Progress - TipRanks
symbol__ Stock Quote Price and Forecast - CNN
Nanobiotix présente les résultats complets de l’étude de Phase 1 évaluant JNJ-1900 (NBTXR3) dans le cancer du pancréas et organise une conférence téléphonique et webcast - GlobeNewswire Inc.
Guggenheim cuts Nanobiotix stock target to $8, maintains buy - Investing.com
Nanobiotix SA ADR Reports 2024 Financial Results - TipRanks
Nanobiotix Stock Gains as Dosing Begins in Mid-Stage NSCLC Study - MSN
Mexico Chitosan Market Size & Outlook, 2022-2030 - Grand View Research
Latin America Chitosan Market Size & Outlook, 2022-2030 - Grand View Research
Middle East & Africa Chitosan Market Size & Outlook, 2030 - Grand View Research
The United States Chitosan Market Size & Outlook, 2030 - Grand View Research
China Chitosan Market Size & Outlook, 2022-2030 - Grand View Research
Japan Chitosan Market Size & Outlook, 2022-2030 - Grand View Research
Nanobiotix announces FDA issuance of Study May Proceed Letter for NBTXR3 study - TipRanks
Nanobiotix (NBTX) Stock Soared 107.9% on a Global Pharma Deal - AskTraders.com
NBTX News Today | Why did Nanobiotix stock go down today? - MarketBeat
Nanobiotix (NBTX) Stock Price, News & Analysis - MarketBeat
Nanobiotix Adr Azioni (NBTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.32%
1.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):